Stonepine Capital Management, LLC

Position in OVID — Ovid Therapeutics Inc.

CIK 1440771 BEND, OR

Position in OVID

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$57,297

-$31,503 QoQ

Shares Held

21,300

-46.8% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#87

of 131 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $108,574,607 across 61 Biotechnology names. OVID ranks #59 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VSTM	Verastem, Inc.	3,349,627	$12,795,575
2	TENX	Tenax Therapeutics, Inc.	660,000	$9,603,000
3	NKTR	Nektar Therapeutics	120,654	$8,422,855
4	ADMA	Adma Biologics, Inc.	740,000	$6,193,800
5	CAMP	Camp4 Therapeutics Corp	1,389,622	$6,072,648
6	ELOX	Eloxx Pharmaceuticals, Inc.	397,160	$5,512,580
7	KZIA	Kazia Therapeutics Ltd	345,179	$4,860,120
8	CRBP	Corbus Pharmaceuticals Holdings, Inc.	425,000	$3,986,500

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$57,297	21,300	-46.8%	Shares	Sole	2026-08-17
2026-03-31	$88,800	40,000	-60.9%	Shares	Sole	2026-05-14
2025-12-31	$166,858	102,367	-93.4%	Shares	Sole	2026-02-13
2022-09-30	$2,834,834	1,540,671	-55.8%	Shares	Sole	2022-11-10
2022-06-30	$7,499,045	3,487,928	-17.3%	Shares	Sole	2022-08-12
2022-03-31	$13,244,736	4,218,069	+5.3%	Shares	Sole	2022-05-16
2021-12-31	$12,859,853	4,006,185	+23.2%	Shares	Sole	2022-02-14
2021-09-30	$10,929,717	3,252,892	+62.6%	Shares	Sole	2021-11-12
2021-06-30	$7,820,000	2,000,000	-19.5%	Shares	Sole	2021-08-16
2021-03-31	$9,981,897	2,483,059	—	Shares	Sole	2021-05-14
No filing history on record for this holder in this stock.